Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MacRae F Linton

Showing results (11-20 of 208) with videos related to

Pageof 21
Sort By:
Journal of the American College of Cardiology|December 3, 2011
Low levels of high-density lipoprotein cholesterol due to lecithin:cholesterol acyltransferase mutations increase carotid atherosclerosisSergio Fazio, MacRae F Linton
Circulation|June 29, 2005
Interplay between apolipoprotein E and scavenger receptor class B type I controls coronary atherosclerosis and lifespan in the mouseSergio Fazio, MacRae F Linton
Circulation. Cardiovascular Genetics|December 20, 2012
When it looks like familial hypercholesterolemia...but is notSergio Fazio, MacRae F Linton
The American Journal of Cardiology|July 18, 2003
A practical approach to risk assessment to prevent coronary artery disease and its complicationsMacRae F Linton, Sergio Fazio,
Arteriosclerosis, Thrombosis, and Vascular Biology|September 4, 2004
Unique pathway for cholesterol uptake in fat cellsSergio Fazio, MacRae F Linton
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 6, 2004
Macrophages, inflammation, and atherosclerosisMacRae F Linton, Sergio Fazio
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"Sergio Fazio, MacRae F Linton
Arteriosclerosis, Thrombosis, and Vascular Biology|April 21, 2012
Inhibition of apolipoprotein(a) synthesis by farnesoid X receptor and fibroblast growth factor 15/19: a step toward selective lipoprotein(a) therapeuticsSergio Fazio, MacRae F Linton
The Journal of Clinical Endocrinology and Metabolism|April 8, 2009
Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogmaSergio Fazio, MacRae F Linton
Current Atherosclerosis Reports|March 17, 2004
The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacySergio Fazio, MacRae F Linton
Pageof 21

Showing results (11-20 of 208) with videos related to

Sort By:
Pageof 21
Journal of the American College of Cardiology|December 3, 2011
Low levels of high-density lipoprotein cholesterol due to lecithin:cholesterol acyltransferase mutations increase carotid atherosclerosisSergio Fazio, MacRae F Linton
Circulation|June 29, 2005
Interplay between apolipoprotein E and scavenger receptor class B type I controls coronary atherosclerosis and lifespan in the mouseSergio Fazio, MacRae F Linton
Circulation. Cardiovascular Genetics|December 20, 2012
When it looks like familial hypercholesterolemia...but is notSergio Fazio, MacRae F Linton
The American Journal of Cardiology|July 18, 2003
A practical approach to risk assessment to prevent coronary artery disease and its complicationsMacRae F Linton, Sergio Fazio,
Arteriosclerosis, Thrombosis, and Vascular Biology|September 4, 2004
Unique pathway for cholesterol uptake in fat cellsSergio Fazio, MacRae F Linton
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 6, 2004
Macrophages, inflammation, and atherosclerosisMacRae F Linton, Sergio Fazio
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"Sergio Fazio, MacRae F Linton
Arteriosclerosis, Thrombosis, and Vascular Biology|April 21, 2012
Inhibition of apolipoprotein(a) synthesis by farnesoid X receptor and fibroblast growth factor 15/19: a step toward selective lipoprotein(a) therapeuticsSergio Fazio, MacRae F Linton
The Journal of Clinical Endocrinology and Metabolism|April 8, 2009
Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogmaSergio Fazio, MacRae F Linton
Current Atherosclerosis Reports|March 17, 2004
The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacySergio Fazio, MacRae F Linton
Pageof 21